US Patent Issued to Boston Scientific Neuromodulation on Oct. 27 for "Systems for determining medication-adjusted clinical effects" (American, German Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,162, issued on Oct. 27, was assigned to Boston Scientific Neuromodulation Corp. (Valencia, Calif.).

"Systems for determining medication-adjusted clinical effects" was invented by Lisa Denise Moore (Glendale, Calif.), Michael A. Moffitt (Solon, Ohio), Leon Mauricio Juarez Paz (Berlin) and Stephen Carcieri (Los Angeles).

According to the abstract* released by the U.S. Patent & Trademark Office: "A system may include at least one medical device and a processing system. The medical device may be configured to treat a condition by delivering a therapy to a patient. The therapy is at least partially defined using a parameter set. The processing system may be configured for use to acqui...